TD Asset Management
BLFS icon

TD Asset Management’s BioLife Solutions BLFS Stock Holding History

TD Asset Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.43M Sell
192,440
-908
-0.5% -$21.2K ﹤0.01% 794
2026
Q1 		$3.69M Buy
193,348
+22,378
+13% +$495K ﹤0.01% 847
2025
Q4 		$4.13M Buy
170,970
+29,638
+21% +$776K ﹤0.01% 834
2025
Q3 		$3.61M Sell
141,332
-2,958
-2% -$70.2K ﹤0.01% 840
2025
Q2 		$3.11M Buy
144,290
+105,470
+272% +$2.38M ﹤0.01% 842
2025
Q1 		$887K Buy
+38,820
New +$1.02M ﹤0.01% 1084

Other funds holding BLFS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

TD Asset Management's BLFS Position: Q2 2026 in Review

TD Asset Management reduced its BioLife Solutions (BLFS) stake by 0.47% in Q2 2026, selling an estimated $21.2K and leaving 192,440 shares worth $5.43M. The position accounts for ﹤0.01% of the portfolio, ranked #794.

TD Asset Management first reported a position in BLFS in Q1 2025 and has held it in 6 quarters since. 155 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • TD Asset Management held 192,440 shares of BioLife Solutions worth $5.43M as of Q2 2026.
  • TD Asset Management sold 908 BioLife Solutions shares in Q2 2026, an estimated $21.2K.
  • BioLife Solutions made up ﹤0.01% of TD Asset Management's portfolio in Q2 2026, its #794 holding.
  • TD Asset Management first reported a position in BioLife Solutions in Q1 2025 and has held it in 6 quarters since.
  • 155 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.